| Net Sales (Q2 2025) | $730.9M | CFO |
| Net Sales Growth (YoY) | +8% | CFO |
| Gross Profit (Q2 2025) | $239.7M | CFO |
| Gross Margin (Q2 2025) | 32.8% | CFO |
| Adjusted EBITDA (Q2 2025) | $105.4M | CFO |
| Adjusted EBITDA Margin (Q2 2025) | 14.4% | CFO |
| Net Income (Q2 2025) | $37.3M | CFO |
| Diluted EPS (Q2 2025) | $0.29 | CFO |
| Adjusted Diluted EPS (Q2 2025) | $0.40 | CFO |
| Net Debt (end Q2 2025) | $878.6M | CFO |
| Net Debt / Adjusted EBITDA | 2.5x | CFO |
| Cash on Hand (end Q2 2025) | $120.1M | CFO |
| Free Cash Flow (6 months) | $25.5M | CFO |
| CapEx (6 months) | $27.9M | CFO |
| Share Repurchases (Q2 2025) | ~576K shares, $6.7M | CFO |
| Pro Forma Combined Adjusted EBITDA (TTM) | ~$639M | CFO |
| Expected Run-Rate Cost Synergies (Year 3) | ~$90M | CEO |
| FY2025 Adjusted EBITDA Guidance | $315M – $365M | CFO |
| FY2025 Adjusted EBITDA Margin Guidance | 12% – 13.5% | CFO |